A$5.84 -0.3 -5.0%
Last Trade - 6:10am
| Market Cap | £1.47bn |
| Enterprise Value | £1.93bn |
| Revenue | £868.4m |
| Position in Universe | 118th / 1834 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | TTM | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|---|
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
ALS Limited is a testing services provider. The principal activities of the Company are the provision of professional technical services in the areas of testing, measurement, inspection and monitoring; food and pharmaceutical quality assurance; mining and mineral exploration; commodity certification; equipment maintenance, and asset care operations. The Company's segments include: ALS Life Sciences, which provides testing data to assist consulting and engineering firms, industry and governments; ALS Industrial, which provides the energy, resources and infrastructure sectors with asset care and tribology testing services; Commodities, which provides assaying and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry such as coal sampling, analysis and certification and formation evaluation services.
| Last Annual | March 31st, 2019 |
| Last Interim | September 30th, 2019 |
| Incorporated | December 8, 1910 |
| Public Since | July 18, 1952 |
| No. of Shareholders: | 9,041 |
| No. of Employees: | 15,000 |
| Sector | Industrials |
| Industry | Professional & Commercial Services |
| Index | S&P/ASX All Ordinaries , S&P/ASX 100 , S&P/ASX 200 , S&P/ASX 300 , S&P/ASX MidCap 50 , FTSE Developed Asia Pacific , FTSE Developed Asia Pacific Ex Japan , |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 482,425,769 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | L 2 299 Coronation Drive, BRISBANE, 4064, Australia |
| Web | https://www.alsglobal.com/ |
| Phone | +61 7 33677900 |
| Auditors | KPMG |
